Ledger.Open graph →
SEC Form D · filed April 26, 2023

Araceli Biosciences Inc

Offering
$4.0M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
TIGARD, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Kirk W. Malloy · Tigard, ORDirectorJ. W. Freytag · Tigard, ORDirectorShawn W. Macdonald · Tigard, ORExecSean W. O'Neill · Tigard, ORDirectorKevin W. Gabelein · Tigard, ORDirectorWilliam B. Cortelyou · Tigard, ORDirectorBruce W. Rhine · Tigard, ORDirectorSamraat W. Raha · Tigard, ORDirectorJeff W. Harris · Tigard, ORExecScott W. Igl · Tigard, ORExecKirk W. Malloy · Tigard, ORDirectorJ. W. Freytag · Broomfield, CODirectorShawn W. Macdonald · Tigard, ORExecSean W. O'Neill · Tigard, ORDirectorKevin W. Gabelein · Tigard, ORDirectorJeff W. Harris · Tigard, ORExecWilliam B. Cortelyou · Tigard, ORDirectorBruce W. Rhine · Tigard, ORDirectorScott W. Igl · Tigard, ORExecSamraat W. Raha · Tigard, ORDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗